ExodusPoint Capital Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-261,381
| Closed | -$1.22M | – | 1598 |
|
|
2024
Q2 | $1.22M | Buy |
+261,381
| New | +$1.22M | 0.01% | 832 |
|
|
2024
Q1 | – | Sell |
-76,147
| Closed | -$771K | – | 1479 |
|
|
2023
Q4 | $771K | Sell |
76,147
-38,643
| -34% | -$391K | 0.01% | 834 |
|
|
2023
Q3 | $895K | Sell |
114,790
-283,301
| -71% | -$2.21M | 0.01% | 962 |
|
|
2023
Q2 | $3.28M | Buy |
398,091
+373,454
| +1,516% | +$3.07M | 0.03% | 527 |
|
|
2023
Q1 | $179K | Buy |
+24,637
| New | +$179K | ﹤0.01% | 1491 |
|
|
2022
Q4 | – | Sell |
-45,521
| Closed | -$557K | – | 1683 |
|
|
2022
Q3 | $557K | Sell |
45,521
-41,908
| -48% | -$513K | 0.01% | 1301 |
|
|
2022
Q2 | $1.03M | Buy |
+87,429
| New | +$1.03M | 0.01% | 1017 |
|
|
2022
Q1 | – | Sell |
-51,369
| Closed | -$1.36M | – | 2237 |
|
|
2021
Q4 | $1.36M | Buy |
51,369
+1,004
| +2% | +$26.7K | 0.01% | 884 |
|
|
2021
Q3 | $2.07M | Buy |
+50,365
| New | +$2.07M | 0.03% | 666 |
|
|
2021
Q2 | – | Sell |
-6,607
| Closed | -$277K | – | 2389 |
|
|
2021
Q1 | $277K | Buy |
6,607
+2,431
| +58% | +$102K | ﹤0.01% | 1677 |
|
|
2020
Q4 | $293K | Sell |
4,176
-42,843
| -91% | -$3.01M | ﹤0.01% | 1482 |
|
|
2020
Q3 | $1.32M | Buy |
47,019
+21,563
| +85% | +$605K | 0.03% | 517 |
|
|
2020
Q2 | $753K | Buy |
+25,456
| New | +$753K | 0.02% | 862 |
|
|
2020
Q1 | – | Sell |
-16,697
| Closed | -$494K | – | 1161 |
|
|
2019
Q4 | $494K | Buy |
+16,697
| New | +$494K | 0.01% | 807 |
|